Back to Companies
Keros Therapeutics, Inc.
KROSNasdaqCIK: 0001664710
Keros Therapeutics, Inc. (KROS) shows 29 recent insider filings from 15 insiders, with 1 buying and 9 selling. With $31.1K in purchases and $180.8M in sales, the recent tape is heavily weighted toward selling (net sales of $180.8M). ADAR1 Capital Management, LLC (10% Owner) is the most active by dollar volume, and the single largest transaction was $95.7M by ADAR1 Capital Management, LLC. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$198.7M
Purchases
$31.1K
Sales
$180.8M
Unique Insiders
15
Recent Insider Trades
29 loaded
| Aug 20 | KROS Keros Therapeutics, Inc. | Lerner Lorena Raquel | Insider | Sell | $36.7K |
| Aug 20 | KROS Keros Therapeutics, Inc. | Tanini Annita | Insider | Sell | $12.6K |
| Aug 20 | KROS Keros Therapeutics, Inc. | Cho Esther | Insider | Sell | $46.2K |
| Aug 20 | KROS Keros Therapeutics, Inc. | Newton Charles W. | Insider | Sell | $5.7K |
| Aug 19 | KROS Keros Therapeutics, Inc. | BIENAIME JEAN JACQUES | Insider | Buy | $10.3K |
| Aug 13 | KROS Keros Therapeutics, Inc. | Tanini Annita | Insider | Other | $0 |
| Jul 17 | KROS Keros Therapeutics, Inc. | BIENAIME JEAN JACQUES | Insider | Buy | $10.6K |
| Jul 6 | KROS Keros Therapeutics, Inc. | Prener Anne | Insider | Other | $0 |
| Jul 6 | KROS Keros Therapeutics, Inc. | Prener Anne | Insider | Grant | $161.8K |
| Jun 17 | KROS Keros Therapeutics, Inc. | BIENAIME JEAN JACQUES | Insider | Buy | $10.2K |
| Jun 15 | KROS Keros Therapeutics, Inc. | Newton Charles W. | Insider | Sell | $5.5K |
| Jun 5 | KROS Keros Therapeutics, Inc. | Seth Alpna | Insider | Sell | $28.1K |
| Jun 8 | KROS Keros Therapeutics, Inc. | Knowles Julius | Insider | Sell | $28.2K |
| Jun 8 | KROS Keros Therapeutics, Inc. | Farzan Nima | Insider | Sell | $28.2K |
| Jun 5 | KROS Keros Therapeutics, Inc. | GRAY MARY ANN | Insider | Grant | $78.0K |
| Jun 5 | KROS Keros Therapeutics, Inc. | Farzan Nima | Insider | Grant | $78.0K |
| Jun 5 | KROS Keros Therapeutics, Inc. | BIENAIME JEAN JACQUES | Insider | Grant | $78.0K |
| Jun 5 | KROS Keros Therapeutics, Inc. | Seth Alpna | Insider | Grant | $78.0K |
| Jun 5 | KROS Keros Therapeutics, Inc. | Knowles Julius | Insider | Grant | $78.0K |
| Apr 6 | KROS Keros Therapeutics, Inc. | Seehra Jasbir | Insider | Exercise | $33.0K |
| Jan 9 | KROS Keros Therapeutics, Inc. | Seehra Jasbir | Insider | Award | $4.0M |
| Dec 18 | KROS Keros Therapeutics, Inc. | GORDON CARL L | Director | Disposed | $3.8M |
| Dec 18 | KROS Keros Therapeutics, Inc. | Knowles Julius | Insider | Disposed | $5.7M |
| Dec 18 | KROS Keros Therapeutics, Inc. | ORBIMED ADVISORS LLC | Director | Disposed | $3.8M |
| Oct 15 | KROS Keros Therapeutics, Inc. | ADAR1 Capital Management, LLC | 10% Owner | Sell | $95.7M |
| Oct 17 | KROS Keros Therapeutics, Inc. | Pontifax Management 4 G.P. (2015) Ltd. | 10% Owner | Sell | $85.0M |
| Sep 5 | KROS Keros Therapeutics, Inc. | Seehra Jasbir | Insider | Grant | $0 |
| Aug 15 | KROS Keros Therapeutics, Inc. | Cho Esther | Insider | Other | $0 |
| Aug 15 | KROS Keros Therapeutics, Inc. | Lerner Lorena Raquel | Insider | Other | $0 |
29 filings